News
The First Wild Gingko e-book: Dietray response to Corona
On February 28, the first forensic anatomy of the remains of a coronavirus victim was undertaken by Professor Liu Liang from Tongji Medical College, Huazhong University of Science and Technology, Wuhan. The following days saw a few more forensic anatomy procedures. The reports from these investigations showed that the deaths were caused by damage first to the lung, then to the liver, and finally to the kidneys and the heart.
The lung is vulnerable to outside attacks since one breathes nonstop. Ginkgo nuts have been regarded as a lung tonic in Traditional Chinese Medicine (TCM), first stated in the pharmacopoeia Shen Nong Ben Cao (Magic Peasant Herb Medica), issued in 2800 Before Christ. They contain properties which may cure coughing, asthma.., and provide benefits for all kinds of lung problems.
The lung in TCM refers to the whole respiratory system, including air passages, the nose and even the skin (which performs micro breathing), besides the lung organ. By the way, my grand uncle happened to be a TCM doctor.
Eating ginkgo nuts will make the lung stronger and less vulnerable to virus. The nuts used to be reserved for the rich in ancient times. Today they are popular in Chinese or Oriental grocery stores.
A handful is enough for a single adult’s daily treatment. Some people, however, are sensitive to even thoroughly cooked nuts. If one is not sure, just start with a few nuts. For children there is a rule: the amount of ginkgo nuts a child can eat is equal to the age, i.e. for a 5-year-old, eat up to 5 nuts only.
The nuts contain compounds that can cause dizziness or symptoms similar to drunkenness. To remedy these symptoms, we villagers usually cook the hard shells of the nuts in water and drink the broth. To be safe, see the doctor promptly if symptoms occur.
I am the headman of a wild ginkgo hamlet in East China. We often eat ginkgo nuts. In our village, no case of coronavirus has occurred so far. And the next but one village has not been lucky. I am also a professional photographer. I have created the world-first wild ginkgo ebook. Taster https://jmp.sh/a0gPjCC
To know more about ginkgos is to know more about how to survive.
If ginkgo nuts are not available, second options are lily, white turnip, lotus seed, apricot, garlic, milk...
Generally speaking, white-colored foods direct more energy towards the lung than other colored foods, so consume white-colored foods when possible to support your lung.
The above foods are for reference only. The same type of produce from different origins may contain different percentages of active properties.
Dietary response is a plus. Daily nutrition and personal prevention measures when going out are always necessary.
After initial panic, life will begin its conservative mode. Although our feet cannot go far, our mind always travels free. Time to take care of our family, to study or to meditate. More babies, scholars and philosophers will surface after the crisis.
Reference:
https://www.medrxiv.org/content/10.1101/2020.02.20.20025619v2
http://finan
Written by Gabriella Gombár
WHO/Europe: Guidance on routine immunization services COVID-19
As a public health emergency of international concern, the COVID-19 pandemic (caused by the novel SARS-CoV-2 virus) has drawn global attention and response. As of 19 March 2020, 51 of 53 countries in the WHO European Region have reported confirmed COVID-19 cases. Each of these countries has initiated a range of measures to mitigate the transmission of SARS-CoV-2 and reduce the impact of the outbreak on healthcare systems, including shifting of healthcare resources to the COVID-19 response.
In planning these measures, due consideration should be given to minimizing the excess risk of morbidity and mortality from vaccine-preventable diseases (VPDs) that would result if immunization services are disrupted. Any disruption of immunization services, even for short periods, will result in an accumulation of susceptible individuals, and a higher likelihood of VPD outbreaks. Such outbreaks may result in VPD-related deaths and an increased burden on health systems already strained by the response to the COVID-19 outbreak.
Written by Gabriella Gombár
theBMJ: Europe’s migrant containment policies vs covid-19
Editorials
Europe’s migrant containment policies threaten the response to covid-19
BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m1213 (Published 26 March 2020)Cite this as: BMJ 2020;368:m1213
Article source : https://www.bmj.com/content/368/bmj.m1213
Correspondence to: S Hargreaves This e-mail address is being protected from spambots. You need JavaScript enabled to view it
- Sally Hargreaves, assistant professor in global health1,
- Bernadette N Kumar, professor2,
- Martin McKee, professor of European public health3,
- Lucy Jones, director of programmes4,
- Apostolos Veizis, director of the Medical Operational Support Unit5
- 1Institute for Infection and Immunity, St George’s University of London, London, UK
- 2Norwegian Institute of Public Health, Oslo, Norway
- 3Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
- 4Doctors of the World, London, UK
- 5Médecins Sans Frontières, Athens, Greece
Policy makers must include migrant camps in their national plans
The world has watched the growing global health crisis caused by covid-19 with alarm, fear, and desperation. One after another, governments, healthcare systems, and individuals are adopting increasingly restrictive measures, with “social distancing” now the norm in most countries. Yet for many people, and especially migrants who have been displaced from their homes, this is not possible.
Several tens of thousands of people are living in migrant camps around the Mediterranean. These are often run well beyond capacity and in suboptimal conditions, including lack of basic infrastructure or hygiene, making them a high risk environment for coronavirus spread. Médecins Sans Frontières (MSF) has called on the Greek government to immediately evacuate its camps, particularly older people and those with chronic diseases, so far without response.1
People held in immigration detention centres are also affected. Demands from 10 refugee and detention charities for UK detainees to be released on public health grounds have been ignored.2 And there are thousands of migrants forcibly detained along the north African coast, intercepted en route to Europe, living in appalling conditions and lacking food, …
For the Full Article go to:https://www.bmj.com/content/368/bmj.m1213Written by Gabriella Gombár
WHO World Immunization Week
WHO World Immunization Week 2020 in the shadow of the COVID-19 Pandemichttps://www.mighealth-unipecs.hu/who-cc
Dear Participants of our previous, traditional WHO Immunization Week round-tables, Dear Colleagues, Dear Website Visitors
|
 |
The current COVID-19 Pandemic underlines the high relevance of WHO traditional program, sentencing one week of each year for the importance of population level vaccination programs. (I would recommend you to study the last paragraph, as a very relevant hypothesis of professor Ternák’s introductory article!) That is why even among the current challenging conditions we would like to keep the traditions and aim to provide you a virtual way of information exchange. Pls. feel welcome to study the selected scientific reviews, focusing now on the current epidemiological situation.
We – as always – would also like to turn your attention on the most vulnerable people, and you are welcome to join to the ‘Leaving no one behind in the Covid-19 Pandemic: an urgent global call to action for inclusion of migrants & refugees in the Covid-19 response’ initiative.’ (See the paper below!)
If you would like to join with a relevant paper to the list below, you are most welcome!
We do believe that in April 2021 we will meet you in person again during the WHO Immunization Week round-table at University of Pécs.
Best regards,
Prof. Dr. Istvan Szilard and the WHO Collaborating Centre’s team at University of Pécs Medical School
- Subjective: Questions to be answered after Covid-19
- COVID-19: Immense necessity and challenges in meeting the needs of minorities, especially asylum seekers and undocumented migrants
- Graphs showing the day-to-day development of the Covid-19 pandemic
- Delivery of immunization services for refugees and migrants (2019)
- A review of evidence on equitable delivery, access and utilization of immunization services for migrants and refugees in the WHO European Region (2017)
- Leaving no one behind in the Covid-19 Pandemic: an urgent global call to action for inclusion of migrants & refugees in the Covid-19 response
Written by Gabriella Gombár
2018 Global Health & Innovation Conference
GHIC Innovation Prize
The Innovation Prize is a $10,000 and a $5,000 cash prize that is awarded to the two best social impact pitches that are presented at the 2018 Global Health & Innovation Conference. All conference registrants -- both students and professionals, and both non-profit and for-profit organizations -- are eligible to apply for the Innovation Prize. Early-stage pitches and established-stage pitches are equally eligible for the $10,000 and $5,000 cash awards. The Innovation Prize supports outstanding ideas, programs, and organizations which are locally-developed and locally-responsible.
There are two categories for the Innovation Prize at the 2018 GHIC: Early Stage (idea, program, or organization is less than 3 years old, and ideas in the brainstorming stage are also eligible) and Established Stage (program or organization is 3-6 years old). A newer program (0-6 years old) that is within an established (7+ year old) organization qualifies for the Social Impact Lab category as well.
Stay updated: Register to receive specialized resources for GHIC Innovation Prize applicants, as well as additional resources for innovators.
- How do I apply?
- What is the deadline?
- What is considered an early-stage or start-up idea, program, or organization?
- What is the Innovation Prize judging criteria?
- Who are the judges?
- Team members
- Innovation Prize cash disbursement
- Conference registration is required
- Past GHIC Innovation Prize winners
- Questions
How do I apply?
- Step 1: Apply for Social Impact Labs. December 15 is the next submission deadline.
First, apply to participate in the Social Impact Labs at the Global Health & Innovation Conference on April 14-15, 2018. Approximately sixty (60) social impact pitches will be selected for presentation during the Social Impact Labs. Applicants first register for the conference and submit a 250-word abstract. The abstract submitters who adhere to the published selection criteria are then invited to submit a 5-minute video pitch within two weeks after being notified of acceptance to the next step. The highest quality pitch videos are accepted, and these presenters participate in the Social Impact Labs. During the Social Impact Lab, each presenter gives a 5-minute pitch, which is followed by a 15-minute period for discussion with two expert conference speakers, questions and answers, and feedback from the audience. Complete details and submission instructions can be seen at http://www.uniteforsight.org/conference/social-enterprise-pitch
- Step 2: Apply for Innovation Prize Semi-Finalist Round
- Those who are accepted as presenters in the Social Impact Labs are next invited to submit an additional 5-minute video presentation and a letter from a local collaborator that confirms that the needs and solutions are locally-identified and locally-responsible. The video presentation should focus on the locally-responsible and innovative solution, with an emphasis on local collaborations and partners, a detailed plan about how data will be collected and how outcomes will be measured, and an outline for how the Innovation Prize funds would be utilized. Up to twenty-five (25) video submitters will be selected as semi-finalists, and they will present a 5-minute pitch to a distinguished judging panel and to the audience at the Global Health & Innovation Conference on April 14-15, 2018. These semi-finalists will participate both in the Social Impact Labs and in the semi-finalist round for the Innovation Prize.
- Step 3: Selection for Innovation Prize Finalist Round
Based on the 5-minute pitches, six Innovation Prize finalists will be selected by the judging panel. Each finalist will give a more in-depth 5-minute presentation to the judging panel and to the audience, which will be followed by 10 minutes of Q&A with the judging panel. These finalists will have participated in the Social Impact Labs, in the semi-finalist round for the Innovation Prize, and in this finalist round for the Innovation Prize. At the conclusion of the 2-hour finalist session, the Innovation Prize winners will be announced.
What is the deadline?
The Innovation Prize application involves three stages:
- 250-word abstract. The next abstract submission deadline to apply for the Social Impact Lab is December 15, 2017. Abstracts submitted by the earlier deadlines are considered more favorably in the committee review since accepted presentations have ample time for continued program progression and evolution.
- 5-minute video pitch. For those invited to submit the video application, the 5-minute video application is due within two weeks of notification about the applicant's invitation to proceed to the next stage. Applicants are either accepted or denied as Social Impact Lab presenters at the 2018 Global Health & Innovation Conference.
- Additional 5-minute video with more comprehensive discussion about the pitch. All accepted to present in the Social Impact Labs at the Global Health & Innovation Conference are invited to apply for the semifinalist round of the GHIC Innovation Prize. In order to be accepted for the GHIC Innovatoin Prize semifinalist round, each applicant will have submitted one 250-word abstract and two 5-minute videos.
What is the Innovation Prize judging criteria?
Gain insight about the judging criteria from the GHIC Innovation Prize judges. What advice do the judges offer about how best to present your pitch in April? How do you ensure a realistic program plan? What are effective tools for outcomes measurements, and how can early-stage ideas and ventures incorporate concrete and effective plans for outcomes? What are pitfalls to avoid? We encourage you to listen to the "Conversation with GHIC Innovation Prize Judges: Learn from Innovation Experts"
The semi-finalists and finalists will be reviewed according to the following criteria:
- Problem: Articulate the problem that your solution is trying to solve. How was the problem identified, and is it clear that this is a locally-identified need?
- Solution: What is your proposed innovative solution? Why is it important? How will it be implemented in the field?
- Innovation: How is the idea new and innovative?
- Based in Evidence: How is your solution evidence-based? Why will it work? We encourage you to read this article about evidence-based program design: http://www.uniteforsight.org/public-health-management/evidence-based-programs
- Locally-Developed and Locally-Responsible: The solution must be based on locally-identified needs, and the role of current local collaborators and partners must be fully delineated.
- Outcomes Measurements: What data will be collected, how will it be collected, and what will be the metrics used for outcome measurements to confirm effectiveness? To help ensure that you effectively identify and discuss outcomes (and not outputs), please read about the critical difference between outputs and outcomes: http://www.uniteforsight.org/global-health-university/outcomes
- Team: Who are the members of the team, what is the role of each, and does the current team have the necessary background and expertise to effectively lead the program?
- Describe Stage of Idea: Are you in the brainstorming stage, early development, or early implementation stage? What is your progress? How much funding, if any, has been raised? When was the idea initially developed? Ideas in the brainstorming, early development, and early implementation stage will be considered equally.
- Presentation: The presentation must be professionally articulated and clearly communicated.
Who are the judges?
- Paul Ellingstad, Managing Partner, PTI Advisors
- Lisa Hirschhorn, Director of Implementation and Improvement Science, Ariadne Labs; Assistant Professor of Clinical Medicine, Harvard Medical School
- Bobby Jefferson, Chief Technology Officer, DAI Global Health
- Jordan Levy, Chief External Relations Officer, Ubuntu Education Fund
- Charles MacCormack, President Emeritus, Save the Children; Executive Chair, Health MDG Alliance
Team members
The conference participant who will be in attendance and presenting the pitch must submit the Social Impact Lab abstract under their name. If selected for participation in the Social Impact Lab, the same team member must apply for the semi-finalist round, and thereafter present in the semi-finalist and finalist sessions.
Innovation Prize cash disbursement
The Innovation Prize must be used for the purposes presented to the judging panel. The Innovation Prize winners will receive the funds in three installments. The first 25% will be disbursed upon submission of a written budget and 1-page written plan for use of the funds. The winners will thereafter submit a written report and receipts for the use of the first 25%, as well as a written budget and 1-page written plan for the use of the next 50% of the funds. The final installment of 25% will be disbursed upon receipt of a written report and receipts for the use of the second funding disbursement.
Conference registration is required
Applying for the Social Impact Lab and for the GHIC Innovation Prize represents a commitment to attend the 2018 Global Health & Innovation Conference, irrespective of acceptance to present at the conference. The opportunity to apply for the opportunities is available only to those who plan to attend the conference for educational and networking purposes, and not to those who wish to attend exclusively for the opportunity to present. Therefore, all persons applying for the Social Impact Lab and for the Innovation Prize must register and submit payment to attend the conference at the time that they submit the social impact pitch abstract.
Innovation Prize Winners
The recipients of the 2017 GHIC Innovation Prize:
- Winner of $10,000: "SubQ Assist: Expanding Access to Long-Term Contraceptive Implants Through Task-Shifting Devices," Ibrahim Mohedas, Post-Doctoral Fellow, University of Michigan Department of Engineering
- Winner of $5,000: "NeMo: Neonatal Monitoring - Providing Tools to Empower Mothers to Identify Neonatal Danger Signs Within the First Week of Life," Rachel An, Project Engineer, Johns Hopkins University
See the 2016 press release here, as well as NextBillion's coverage of the winners.The recipients of the 2016 GHIC Innovation Prize:
- Winner of $10,000: “Innovative Clean Cookstove: Saving Lives from Smoke-Pollution,” Maxwell Chinnah, CEO and Co-Founder, Terraoak, Inc.
- Winner of $2,000: “Highlight: Powdered Additive for Disinfectants to Improve Infectious Disease Decontamination,” Jason Kang, Co-Founder, Kinnos
- Winner of $2,000: “Everwaters: A Social Venture Pioneering Plant-Based, Water Treatment Technology to Combat the Global Water Crisis,” Adrian Lievano, Co-Founder and CEO, Everwaters
The recipients of the 2015 GHIC Innovation Prize:
- Winner of $10,000: "An Innovative and Low-Cost Solution for Clubfoot Treatment: The Miraclefeet Brace," Lucy Topaloff, Program Coordinator, miraclefeet
- Winner of $5,000:"Mobile Health for Surgical Follow Up: A Global Innovation," Alexi Matousek, Global Health Equity Resident in Surgery, The Center for Surgery and Public Health, Brigham and Women's Hospital, The Program in Global Surgery and Social Change, Dept of Global Health and Social Medicine, Harvard Medical School
Questions?
If you have any questions, please email Amy Bellman Davis at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .
Written by Gabriella Gombar
More Articles...
Page 14 of 47